Sexual, reproductive, maternal, newborn, child and adolescent health: report on the 2023 policy survey

Table of Contents

• Acknowledgements 18
• Abreviations 19
• Executive summary 20
• 1. Introduction 26
• 2. Methods 29
• 2.1 Development of survey tool 29
• 2.2 Survey administration 29
• 2.3 Data processing 30
• 2.4 Data analysis 30
• 3. Response rate 32
• 4. Cross-cutting areas in SRMNCAH 35
• 4.1 Key points on availability of national policies/guidelines/laws in cross-cutting areas 35
• 4.2 Availability of national strategies/plans and coordinating bodies for SRMNCAH 37
• 4.3 Availability of national policies/guidelines on quality of care for SRMNCAH services 40
• 4.4 Availability of national legislation on the rights of the child to health and health care 42
• 4.5 Availability of national policies and legislation on birth registration 42
• 5. Maternal and newborn health 45
• 5.1 Key points on availability of national policies/guidelines/laws on maternal and newborn health 45
• 5.2 Availability of national strategic plans 48
• 5.3 Availability of national antenatal care policies 49
• 5.3.1 Availability of national policies/guidelines on number and timing of antenatal care contacts 49
• 5.3.2 Availability of national policies/guidelines on components of antenatal care 51
• 5.3.3 Availability of national policies/guidelines on use of antenatal corticosteroids 52
• 5.4 Availability of national policies/guidelines related to childbirth 53
• 5.5 Availability of national policies/guidelines on postnatal care for mothers and newborns 54
• 5.5.1 Availability of national policies/guidelines on essential newborn care 55
• 5.5.2 Availability of national policies/guidelines on the minimum length of stay in a facility and discharge criteria 56
• 5.5.3 Availability of national policies/guidelines on number of routine postnatal contacts 58
• 5.5.4 Availability of national policies/guidelines on home visits for postnatal contact during first week after birth 59
• 5.5.5 Availability of national policies/guidelines on postnatal care for the woman and baby and newborn screening 60
• 5.5.6 Availability of national birth defect surveillance systems 61
• 5.6 Availability and components of national policies/guidelines on the care of small and sick newborns 62
• 5.6.1 Availability and components of national policies/guidelines on the management of low-birth-weight and preterm newborns 62
• 5.6.2 Availability of national standards on management of newborns with severe illness 64
• 5.7 Availability of national policies exempting user fees for services in the public sector for mothers and newborns 65
• 5.8 Availability of national policies/guidelines on the education of midwifery care providers 66
• 5.9 Availability of national policies/guidelines/laws on maternal or perinatal death surveillance and response 67
• 6. Child health 71
• 6.1 Key points on availability of national policies/guidelines/laws on child health 71
• 6.2 Availability of national strategic plan on child health 73
• 6.3 Availability of national policies/guidelines on management of childhood pneumonia, diarrhoea, and malaria 74
• 6.3.1 Availability of national policies/guidelines on management of pneumonia in children 74
• 6.3.2 Availability of national policies/guidelines on management of diarrhoea in children 77
• 6.4 Availability of national policies/guidelines on provision of IMCI 79
• 6.5 Availability of national policies/guidelines on paediatric hospital care for sick children 81
• 6.6 Availability of national policies/guidelines on early childhood development 82
• 6.7 Availability of national policies exempting user fees for services in the public sector for children 85
• 7. Adolescent health 87
• 7.1 Key points on availability of national guidelines/policies/laws on adolescent health 87
• 7.2 Availability of national strategic plans/policies/guidelines on adolescent health 89
• 7.3 Availability, components, and monitoring of national standards for delivery of health services to adolescents 90
• 7.4 Availability and components of national standards for health-promoting schools 92
• 7.5 Availability of national programmes on adolescent health 92
• 7.6 Existence of national policies/guidelines on age limits for adolescents’ ability to consent to certain interventions without parental/spousal consent 94
• 7.7 Availability of national policies exempting user fees for services in the public sector for adolescents 96
• 7.8 Availability of national laws/policies on novice drivers and alcohol marketing and sale 97
• 8. Sexual and reproductive health 99
• 8.1 Key points on availability of national guidelines/policies/laws on sexual and reproductive health 99
• 8.2 Availability of national strategic plans/policies/guidelines on sexual and reproductive health care 100
• 8.3 Availability of national policies/guidelines on family planning/contraception 102
• 8.3.1 Availability of national clinical practice guidelines on family planning/contraception 104
• 8.4 Availability of national policies/guidelines on STIs 106
• 8.5 Availability and components of national policies/guidelines on comprehensive national cervical cancer prevention 107
• 8.5.1 Availability of national policies exempting user fees for cervical cancer services in the public sector 107
• 8.6 Availability of national laws/policies/guidelines on, and financial support for, infertility management 108
• 8.7 Availability of national laws/policies/guidelines on sexual health 109
• 8.7.1 Availability of non-discrimination provisions in national policies/guidelines/laws on sexual health services 110
• 8.7.2 Availability of a policies/laws prohibiting harmful practices 110
• 8.7.3 Existence of policies/laws prohibiting same-sex relationships or behaviours 110
• 8.7.4 Availability of national policies/guidelines/laws on mandatory comprehensive sexuality education in the regular education system 110
• 8.8 Availability of national policies/guidelines on self-care interventions for sexual and reproductive health 112
• 8.9 Availability of national policies exempting user fees for services in the public sector for women of reproductive age 114
• 9. Violence against women 116
• 9.1 Methods 116
• 9.2 Key points on availability of national guidelines/policies on violence against women 117
• 9.3 Enabling environment 117
• 9.4 Woman-centred care 118
• 9.5 Health services for survivors of intimate partner violence and sexual violence 119
• 9.6 Adolescent girls and young women as a priority population 120
• 9.7 Conclusions 120
• References 122
• Annex 1: Sexual, reproductive, maternal, newborn, child and adolescent health policy survey 2023 questionnaire 126
• Annex 2: Country tables 130
• Annex 3. Region tables 190
• Annex 4. Countries, territories, areas that completed the 2023 WHO SRMNCAH policy survey 241
• Table 1. Response rate to 2023 WHO SRMNCAH policy survey 33
• Table 2. Summary of availability of selected cross-cutting SRMNCAH policies/guidelines/laws, by WHO region and World Bank income group, as reported in 2023 WHO SRMNCAH Policy Survey 35
• Table 3. Summary of availability of selected policies/guidelines/laws on maternal and newborn health, by WHO region and World Bank income group, as reported in 2023 WHO SRMNCAH policy survey 45
• Table 4. Summary of availability of selected policies/guidelines/laws on child health, by WHO region and World Bank income group, as reported in 2023 WHO SRMNCAH policy survey 72
• Table 5. Summary of availability of selected policies/guidelines/laws on adolescent health, by WHO region and World Bank income group, as reported in 2023 WHO SRMNCAH policy survey 88
• Table 6. Summary of availability of selected policies/guidelines/laws on sexual and reproductive health, by WHO region and World Bank income group, as reported in 2023 WHO SRMNCAH policy survey 99
• Table 7. Policy/guideline on self-care interventions for sexual and reproductive health includes specified interventions, as reported in 2023 WHO SRMNCAH policy survey 113
• Fig. 1. Proportional existence of 14 selected policies/guidelines/strategies, by country, as reported in 2023 WHO SRMNCAH policy survey 21
• Fig. 2. WHO Member States that completed the 2023 WHO SRMNCAH policy survey 32
• Fig. 3. Integrated strategy/plan for SRMNCAH, as reported in 2023 WHO SRMNCAH policy survey 37
• Fig. 4. Existence of national coordinating body responsible for developing, implementing, or oversight of any SRMNCAH strategy, policy, or plans, by WHO region, as reported in 2018–2019 and 2023 WHO SRMNCAH policy surveys 38
• Fig. 5. Stakeholders typically included in national SRMNCAH coordinating body, as reported in 2023 WHO SRMNCAH policy survey 38
• Fig. 6. Meeting frequency of national SRMNCAH coordinating body, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 39
• Fig. 7. Stakeholders that participate in reviews of SRMNCAH plans, as reported in 2023 WHO SRMNCAH policy survey 39
• Fig. 8. Existence of national policy/guideline to improve quality of care that includes or is specific to any SRMNCAH services, by WHO region, as reported in 2018–2019 and 2023 WHO SRMNCAH policy surveys 40
• Fig. 9. National quality of care standards and protocols for delivery of services in health facilities developed for any SRMNCAH services, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 41
• Fig. 10. National quality of care standards and protocols for delivery of services in health facilities developed for any SRMNCAH services, by service area, as reported in 2023 WHO SRMNCAH policy survey 41
• Fig. 11. National child rights/child welfare/child protection legislation, as reported in 2023 WHO SRMNCAH policy survey 42
• Fig. 12. Policy requirements and process for birth registration, as reported in 2023 WHO SRMNCAH policy survey 43
• Fig. 13. Strategic plan exists for maternal and newborn health, as reported in 2023 WHO SRMNCAH policy survey and 2021 European action plan for sexual and reproductive health survey 48
• Fig. 14. Recommended number of antenatal care contacts for a normal pregnancy indicated in national antenatal care policy/guideline, by WHO region, as reported in 2018–2019 and 2023 WHO policy surveys 49
• Fig. 15. Recommended timing of first antenatal care contact as indicated in national antenatal care policy/guideline, by WHO region, as reported in 2018–2019 and 2023 WHO policy surveys 50
• Fig. 16. Content of policy/guideline on antenatal care for normal pregnancies, as reported in 2023 WHO SRMNCAH policy survey 51
• Fig. 17. Recommendation of use of antenatal corticosteroids for prevention of preterm birth complications in national policy/guideline, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 52
• Fig. 18. Availability of selected national policies/guidelines related to childbirth as reported in 2023 WHO SRMNCAH policy survey 53
• Fig. 19. National policy/guideline on postnatal care for women and/or newborns, by WHO region, as reported in 2018–2019 and 2023 WHO SRMNCAH policy surveys 54
• Fig. 20. National policies/guidelines on essential newborn care that recommend selected interventions as reported in WHO 2023 SRMNCAH policy survey 55
• Fig. 21. National policy/guideline that recommends that woman and newborn be kept together from birth until they are discharged from a facility, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 56
• Fig. 22. Recommended minimum length of stay in a facility for woman and newborn after normal vaginal birth per national policy/guideline, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 57
• Fig. 23. Recommended minimum length of stay in a facility for woman and newborn after caesarean section per national policy/guideline, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 57
• Fig. 24. National policy/guideline specifies criteria for discharge for the woman and/or newborn after facility birth, as reported in 2023 WHO SRMNCAH policy survey 58
• Fig. 25. Number of routine postnatal contacts recommended in the national policy/guideline, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 58
• Fig. 26. National policy/guideline recommends a home visit for the postnatal contact during the first week after birth, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 59
• Fig. 27. Specified interventions recommended in national policy/guideline on postnatal care, as reported in 2023 WHO SRMNCAH policy survey 60
• Fig. 28. Newborn conditions for which national policy/guideline recommends screening, as reported in 2023 WHO SRMNCAH policy survey 61
• Fig. 29. Birth defect surveillance system exists in the country, as reported in the 2023 WHO SRMNCAH policy survey 61
• Fig. 30. National policy/guideline on management of low-birth-weight and preterm newborns, by WHO region, as reported in 2018–2019 and 2023 WHO SRMNCAH policy surveys 62
• Fig. 31. National policy/guideline that recommends preterm/low-birth-weight newborns, including those with very low birth weight, should be fed breastmilk, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 63
• Fig. 32. National policies/guidelines on care for preterm/low-birth-weight newborns, as reported in the 2023 WHO SRMNCAH policy survey 63
• Fig. 33. National policy/guideline that recommends CPAP as the primary means of respiratory support for preterm infants with respiratory distress 64
• Fig. 34. National policies/guidelines for the management of newborn infants with severe illness, by WHO region, as reported in 2018–2019 and 2023 WHO SRMNCAH policy surveys 64
• Fig. 35. National policy/guideline for treatment of young infants (aged 0–59 days) with possible serious bacterial infection at primary health facility when referral is not feasible, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 65
• Fig. 36. Specified health services to be provided free of charge in public sector for women of reproductive age per national policy, as reported in the 2023 WHO SRMNCAH policy survey 66
• Fig. 37. Specified health services to be provided free of charge at point of care in public sector for newborns per national policy, as reported in the 2023 WHO SRMNCAH policy survey 66
• Fig. 38. National policies/guidelines on midwifery, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 67
• Fig. 39. National policy/guideline/law that requires audit and/or review of maternal or perinatal death, as reported in 2023 WHO SRMNCAH policy survey and 2021 European action plan for sexual and reproductive health survey 68
• Fig. 40. National policy/guideline/law requiring maternal and perinatal deaths to be notified to a central authority, as reported in 2023 WHO SRMNCAH policy survey 68
• Fig. 41. National policy/guideline requiring classification of the causes of maternal deaths according to the ICD-MM, by WHO region, as reported in 2018–2019 and 2023 WHO SRMNCAH policy surveys 69
• Fig. 42. Strategic plan exists for child health, as reported in 2023 WHO SRMNCAH policy survey 73
• Fig. 43. National policy/guideline on the management of childhood pneumonia for children 2–59 months of age and 5–9 years of age, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 74
• Fig. 44. Level of health system at which pneumonia with chest in-drawing can be treated per national policy/guideline, by WHO region, as reported in 2018–2019 and 2023 WHO SRMNCAH policy surveys 75
• Fig. 45. First-line treatment for pneumonia with chest in-drawing and fast breathing per national policy/guideline, as reported in 2018–2019 and 2023 WHO SRMNCAH policy surveys 76
• Fig. 46. Recommended duration of treatment for pneumonia with fast breathing per national policy/guideline, by WHO region, as reported in 2018–2019 and 2023 WHO SRMNCAH policy surveys 76
• Fig. 47. National policy/guideline on management of childhood diarrhoea, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 77
• Fig. 48. Recommended treatment for diarrhoea with dehydration per national policy/guideline, by WHO region, as reported in the 2018–2019 and 2023 WHO SRMNCAH policy surveys 77
• Fig. 49. National policy/guideline on the management of malaria with recommendations for children, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 78
• Fig. 50. Recommended first-line treatment for malaria per national policy/guideline as reported in 2023 WHO SRMNCAH policy survey 78
• Fig. 51. National policy/guidelines on prevention of malaria as reported in 2023 WHO SRMNCAH policy survey 79
• Fig. 52. National policy/guideline on IMCI, as reported in 2023 WHO SRMNCAH policy survey 79
• Fig. 53. National policy/guideline on iCCM, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 80
• Fig. 54. Activities that can be conducted by CHWs per national policy/guideline, as reported in 2023 WHO SRMNCAH policy survey 80
• Fig. 55. National policy/guideline and clinical standards for management of children with severe illness in hospitals, by WHO region, as reported in 2018–2019 and 2023 WHO SRMNCAH policy surveys 81
• Fig. 56. National policy/guideline on early childhood development, as reported in 2023 WHO SRMNCAH policy survey 82
• Fig. 57. Content of national policy/guideline on early childhood development, as reported in 2023 WHO SRMNCAH policy survey 83
• Fig. 58. National coordination mechanism for early childhood development, by WHO region, as reported in 2018–2019 and 2023 WHO SRMNCAH policy surveys 84
• Fig. 59. Involvement of sectors in national coordination mechanism for early childhood development, as reported in 2023 WHO SRMNCAH policy survey 84
• Fig. 60. Exemptions from user fees for children in public sector, per national policy, for specified health services, as reported in 2023 WHO SRMNCAH policy survey 85
• Fig. 61. Strategic plan exists for adolescent health/well-being, as reported in 2023 WHO SRMNCAH policy survey and 2021 European action plan for sexual and reproductive health survey 89
• Fig. 62. Adolescents cited as a specific target group for defined interventions/activities in a national policy/guideline for the following health issues, as reported in 2023 WHO SRMNCAH policy survey 90
• Fig. 63. National standards for delivery of health services to adolescents, by WHO region, as reported in 2018–2019 and 2023 WHO SRMNCAH policy surveys 91
• Fig. 64. Availability, components, and monitoring of national standards for delivery of health services to adolescents, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 91
• Fig. 65. Availability of national standards for health-promoting schools and related monitoring activities, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 92
• Fig. 66. National adolescent health/well-being programme, by WHO region, computed from responses to 2018–2019 and 2023 WHO SRMNCAH policy surveys 93
• Fig. 67. At least one designated full-time person for the national adolescent health/well-being programme, by WHO region, as reported in 2018–2019 and 2023 WHO SRMNCAH policy surveys 93
• Fig. 68. Regular government budget allocation to support the national adolescent health/well-being programme, by WHO region, as reported in 2018–2019 and 2023 WHO SRMNCAH policy surveys 94
• Fig. 69. Existence of age limit for different types of service for unmarried adolescents to provide consent without parental/legal guardian consent, as reported in 2023 WHO SRMNCAH policy survey and 2020 European child and adolescent health strategy surve 95
• Fig. 70. Existence of age limit for different types of service for married adolescents to provide consent without spousal consent, as reported in 2023 WHO SRMNCAH policy survey 95
• Fig. 71. Exemptions from user fees for adolescents in public sector, per national policy, for specified health services, as reported in 2023 WHO SRMNCAH policy survey 96
• Fig. 72. Existence of laws/policies to provide graduated licensing for novice drivers, designate a minimum age for the sale alcoholic beverages, and regulate marketing of alcohol to minors, as reported in 2023 WHO SRMNCAH policy survey 97
• Fig. 73. Strategic plan exists for sexual and reproductive health, as reported in 2023 WHO SRMNCAH policy survey and 2021 European action plan for sexual and reproductive health survey 101
• Fig. 74. National policies/guidelines on sexual and reproductive health care, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 101
• Fig. 75. Policies/guidelines for competencies and continuous professional education for health providers in sexual and reproductive health care, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 102
• Fig. 76. National policy/guideline on family planning/contraception, as reported in 2023 WHO SRMNCAH policy survey and 2021 European action plan for sexual and reproductive health survey 103
• Fig. 77. National policy/guideline on family planning/contraception has provisions that restrict access to these services to selected population groups, as reported in 2023 WHO SRMNCAH policy survey 103
• Fig. 78. National clinical practice guidelines on family planning/contraception, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 104
• Fig. 79. Cadres of health workers allowed to independently perform selected services, other than a specialist doctor, as reported in 2023 WHO SRMNCAH policy survey 105
• Fig. 80. National policies /guidelines on STI diagnosis, treatment, and counselling, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 106
• Fig. 81. Content of national strategies/policies /guidelines on STIs, as reported in 2023 WHO SRMNCAH policy survey 106
• Fig. 82. Existence of national cervical cancer prevention and control policy/guideline, as reported in 2023 WHO SRMNCAH policy survey and 2021 European action plan for sexual and reproductive health survey 107
• Fig. 83. Services recommended in national policy/guideline on cervical cancer prevention and control as reported in 2023 WHO SRMNCAH policy survey 108
• Fig. 84. Laws/policies/guidelines on infertility management, by WHO region, as reported in 2023 WHO SRMNCAH policy survey and 2021 European action plan for sexual and reproductive health survey 108
• Fig. 85. Existence of programmes that provide financial support for the individual use of assisted fertility services, as reported in 2023 WHO SRMNCAH policy survey and 2021 European action plan for sexual and reproductive health survey 109
• Fig. 86. Existence of national policies/laws/guidelines on sexual health services, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 109
• Fig. 87. Provisions for non-discrimination against selected criteria/groups included in laws/policies/guidelines on sexual health, as reported in 2023 WHO SRMNCAH policy survey 110
• Fig. 88. Existence of policies/laws that prohibit various actions, behaviours, or relationships, as reported in 2023 WHO SRMNCAH policy survey 111
• Fig. 89. Policies /laws/guidelines for mandatory comprehensive sexuality education as part of the regular educational curriculum, by WHO region, as reported in 2023 WHO SRMNCAH policy survey and 2021 European action plan for sexual and reproductive health 111
• Fig. 90. Minimum age of consent to marriage for women/girls and men/boys, as reported in 2023 WHO SRMNCAH policy survey 112
• Fig. 91. Existence of national policy/guideline on self-care interventions for sexual and reproductive health, as reported in 2023 WHO SRMNCAH policy survey 113
• Fig. 92. Specified health services to be provided free of charge in public sector for women of reproductive age per national policy, as reported in the 2023 WHO SRMNCAH policy survey 114
• Fig. 93. Availability of national health policies that include VAW, multisectoral VAW policies, or health sector VAW policies (VAW clinical guidelines), by WHO region 118
• Fig. 94. Percentage of countries that include violence against women survivors’ right to privacy in practice, right to privacy as a principle, or both in their available policies 118
• Fig. 95. Percentage of countries that include first-line support for survivors of violence against women in their available policies 119
• Fig. 96. Percentage of countries that recognize that adolescent girls and/or young women are disproportionately affected by violence against women in their available national plan, policy, or protocol, by WHO region 120
• Table A2.1. Existence of selected SRMNCAH policies/guidelines by country as reported in the 2023 WHO SRMNCAH policy survey 130
• Table A2.2. Existence of selected cross-cutting SRMNCAH policies/guidelines/laws by country, as reported in the 2023 WHO SRMNCAH policy survey 142
• Table A2.3. Existence of selected policies/guidelines/laws on maternal and newborn health by country, as reported in the 2023 WHO SRMNCAH policy survey 150
• Table A2.4. Existence of selected policies/guidelines/laws on child health by country, as reported in the 2023 WHO SRMNCAH policy survey 166
• Table A2.5. Existence of selected policies/guidelines/laws on adolescent health by country, as reported in the 2023 WHO SRMNCAH policy survey 174
• Table A2.6. Existence of selected policies/guidelines/laws on sexual and reproductive health by country, as reported in the 2023 WHO SRMNCAH policy survey 182
• Table A3.45. Percentage of countries that recognize the high risk of violence faced by adolescent girls and young women and include specific services for them in their policies, by WHO region 240
• Table A3.44. Percentage of countries that state how services should be specific to the needs of adolescent girls and young women in their available policies, by WHO region 239
• Table A3.43. Percentage of countries that recognize that adolescent girls and/or young women are a population disproportionately affected by violence against women in their available national plan, policy, or protocol, by WHO region 239
• Table A3.42. Percentage of countries that make reference to mental health treatment in their available policies, by WHO region 238
• Table A3.41. Percentage of countries that include mental health assessment and/or referral to specialist services in their available policies, by WHO region 238
• Table A3.40. Percentage of countries that include first-line support for violence against women in their available health policies WHO region 237
• Table A3.39. Percentage of countries that include universal screening to identify intimate partner violence in their available policies (not recommended), by WHO region 237
• Table A3.38. Percentage of countries that include clinical inquiry to identify intimate partner violence in their available policies (recommended), by WHO region 236
• Table A3.37. Percentage of countries that include violence against women survivors’ right to privacy in practice, right to privacy as a principle, or both in their available policies, by WHO region 236
• Table A3.36. Percentage of countries that include mandatory reporting of violence against women by health providers in their available policies (not recommended), by WHO region 235
• Table A3.35. Availability of health sector violence policies (violence against women clinical guidelines), by WHO region 235
• Table A3.34. Availability of a multisectoral violence against women prevention and response policy, by WHO region 234
• Table A3.33. Availability of a national health policy specifying violence against women as a strategic priority, by WHO region 234
• Table A3.32. Availability of a national health policy that includes violence against women, by WHO region 234
• Table A3.31. Specified health services to be provided free of charge in public sector for women of reproductive age per national policy, as reported in the 2023 WHO SRMNCAH policy survey 233
• Table A3.30. Existence of policies/laws that prohibit various actions, behaviours, or relationships, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 232
• Table A3.29. Provisions for non-discrimination against selected criteria/groups included in laws/policies/guidelines on sexual health, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 231
• Table A3.28. Services recommended in national policy/guideline on cervical cancer prevention and control, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 229
• Table A3.27. Content of national strategies/policies/guidelines on STIs, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 228
• Table A3.26. Cadres of health workers allowed to independently perform selected services, other than a specialist doctor, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 227
• Table A3.25. National policy/guideline on family planning/contraception has provisions that restrict access to these services to selected population groups, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 226
• Table A3.24. Exemptions from user fees for adolescents in public sector, per national policy, for specified health services, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 224
• Table A3.23. Existence of age limit for different types of service for married adolescents to provide consent without spousal consent, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 222
• Table A3.22. Existence of age limit for different types of service for unmarried adolescents to provide consent without parental/legal guardian consent, by WHO region, as reported in 2023 WHO SRMNCAH policy survey and 2020 European child and adolescent h 220
• Table A3.21. Adolescents cited as a specific target group for defined interventions/activities in a national policy/guideline for the following health issues, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 220
• Table A3.20. Exemptions from user fees for children in public sector, per national policy, for specified health services, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 219
• Table A3.19. Involvement of sectors in national coordination mechanism for early childhood development, as reported in 2023 WHO SRMNCAH policy survey 217
• Table A3.18. Content of national policy/guideline on early childhood development, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 216
• Table A3.17. Conditions addressed in national policy/guideline on IMCI, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 214
• Table A3.16. First-line treatment for pneumonia with chest in-drawing and fast breathing per national policy/guideline, by WHO region, as reported in 2018–2019 and 2023 WHO SRMNCAH policy surveys 213
• Table A3.15. National policy/guideline/law requiring maternal and perinatal deaths to be notified to a central authority, as reported in 2023 WHO SRMNCAH policy survey 212
• Table A3.14. Specified health services to be provided free of charge at point of care in public sector for newborns per national policy, by WHO region, as reported in the 2023 WHO SRMNCAH policy survey 211
• Table A3.13. Specified health services to be provided free of charge in public sector for women of reproductive age per national policy, by WHO region, as reported in the 2023 WHO SRMNCAH policy survey 209
• Table A3.12. National policies/guidelines on care for preterm/low-birth-weight newborns, by WHO region, as reported in the 2023 WHO SRMNCAH policy survey 207
• Table A3.11. Birth defect surveillance system exists in the country, by WHO region, as reported in the 2023 WHO SRMNCAH policy survey 207
• Table A3.10. Newborn conditions for which national policy/guideline recommends screening, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 206
• Table A3.9. Specified interventions recommended in national policy/guideline on postnatal care, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 205
• Table A3.8. National policies/guidelines on essential newborn care that recommend selected interventions, by WHO region, as reported in WHO 2023 SRMNCAH policy survey 203
• Table A3.7. Availability of selected national policies/guidelines related to childbirth, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 201
• Table A3.6. Content of policy/guideline on antenatal care for normal pregnancies, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 199
• Table A3.5. Policy requirements and process for birth registration, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 197
• Table A3.4. National quality of care standards and protocols for delivery of services in health facilities developed for any SRMNCAH services, by service area and by WHO region, as reported in 2023 WHO SRMNCAH policy survey 195
• Table A3.3. Stakeholders that participate in reviews of SRMNCAH plans, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 193
• Table A3.2 Stakeholders typically included in national SRMNCAH coordinating body, by WHO region, as reported in 2023 WHO SRMNCAH policy survey 191
• Table A3.1. Existence of selected SRMNCAH policies/guidelines, by WHO region and World Bank income group, as reported in 2023 WHO SRMNCAH policy survey 190
• Table A4.1. Countries, territories, areas that completed the 2023 WHO SRMNCAH policy survey by WHO region 241
• Table A4.2. Countries, territories, areas that completed the 2023 WHO SRMNCAH policy survey by World Bank income 243
• Annex 1: Sexual, reproductive, maternal, newborn, child and adolescent health policy survey 2023 questionnaire 126
• Annex 2: Country tables 130
• Annex 3. Region tables 190
• Annex 4. Countries, territories, areas that completed the 2023 WHO SRMNCAH policy survey 241